Navidea Biopharmaceuticals PE Ratio 2006-2019 | NAVB
Current and historical p/e ratio for Navidea Biopharmaceuticals (NAVB) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Navidea Biopharmaceuticals PE ratio as of September 16, 2019 is 0.00.
| Navidea Biopharmaceuticals PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2019-09-16 | 0.74 | 0.00 | |
| 2019-06-30 | 0.63 | $-1.28 | 0.00 |
| 2019-03-31 | 0.14 | $-1.44 | 0.00 |
| 2018-12-31 | 0.10 | $-2.00 | 0.00 |
| 2018-09-30 | 0.23 | $-2.20 | 0.00 |
| 2018-06-30 | 0.23 | $-2.00 | 0.00 |
| 2018-03-31 | 0.36 | $-2.20 | 0.00 |
| 2017-12-31 | 0.36 | $9.00 | 0.04 |
| 2017-09-30 | 0.42 | $9.20 | 0.05 |
| 2017-06-30 | 0.51 | $9.40 | 0.05 |
| 2017-03-31 | 0.58 | $9.20 | 0.06 |
| 2016-12-31 | 0.64 | $-1.60 | 0.00 |
| 2016-09-30 | 0.92 | $-1.60 | 0.00 |
| 2016-06-30 | 0.53 | $-2.60 | 0.00 |
| 2016-03-31 | 0.94 | $-3.00 | 0.00 |
| 2015-12-31 | 1.33 | $-3.60 | 0.00 |
| 2015-09-30 | 2.28 | $-4.20 | 0.00 |
| 2015-06-30 | 1.61 | $-4.20 | 0.00 |
| 2015-03-31 | 1.59 | $-4.40 | 0.00 |
| 2014-12-31 | 1.89 | $-5.00 | 0.00 |
| 2014-09-30 | 1.32 | $-6.00 | 0.00 |
| 2014-06-30 | 1.48 | $-6.80 | 0.00 |
| 2014-03-31 | 1.85 | $-7.20 | 0.00 |
| 2013-12-31 | 2.07 | $-6.80 | 0.00 |
| 2013-09-30 | 2.65 | $-6.20 | 0.00 |
| 2013-06-30 | 2.67 | $-6.20 | 0.00 |
| 2013-03-31 | 2.71 | $-5.60 | 0.00 |
| 2012-12-31 | 2.83 | $-5.80 | 0.00 |
| 2012-09-30 | 2.75 | $-6.00 | 0.00 |
| 2012-06-30 | 3.72 | $0.00 | 0.00 |
| 2012-03-31 | 3.28 | $0.80 | 4.10 |
| 2011-12-31 | 2.62 | $1.20 | 2.18 |
| 2011-09-30 | 2.96 | $2.20 | 1.35 |
| 2011-06-30 | 3.32 | $-2.60 | 0.00 |
| 2011-03-31 | 3.95 | $-15.00 | 0.00 |
| 2010-12-31 | 2.06 | $-14.60 | 0.00 |
| 2010-09-30 | 1.88 | $-14.00 | 0.00 |
| 2010-06-30 | 1.80 | $-20.20 | 0.00 |
| 2010-03-31 | 1.64 | $-11.60 | 0.00 |
| 2009-12-31 | 1.22 | $-10.80 | 0.00 |
| 2009-09-30 | 1.40 | $-11.20 | 0.00 |
| 2009-06-30 | 0.95 | $-5.00 | 0.00 |
| 2009-03-31 | 0.54 | $-1.00 | 0.00 |
| 2008-12-31 | 0.57 | $-1.60 | 0.00 |
| 2008-09-30 | 0.57 | $-1.80 | 0.00 |
| 2008-06-30 | 0.68 | $-1.40 | 0.00 |
| 2008-03-31 | 0.35 | $-1.60 | 0.00 |
| 2007-12-31 | 0.29 | $-1.60 | 0.00 |
| 2007-09-30 | 0.31 | $-1.40 | 0.00 |
| 2007-06-30 | 0.27 | $-1.80 | 0.00 |
| 2007-03-31 | 0.24 | $-1.60 | 0.00 |
| 2006-12-31 | 0.24 | $-1.60 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.007B | $0.001B |
| Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents for diseases such as cancer and Alzheimer. The Company's radiopharmaceutical development programs include: Lymphoseek(R), AZD4694 and RIGScan(TM). Navidea Biopharmaceuticals, Inc., formerly Neoprobe Corporation, is headquartered in Dublin, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $119.202B | 25.40 |
| Intuitive Surgical (ISRG) | United States | $60.303B | 52.74 |
| Edwards Lifesciences (EW) | United States | $45.649B | 44.43 |
| IDEXX Laboratories (IDXX) | United States | $22.854B | 57.34 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $21.053B | 14.13 |
| Olympus (OCPNY) | Japan | $18.002B | 0.00 |
| Teleflex (TFX) | United States | $15.310B | 32.50 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.143B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $13.974B | 37.67 |
| DexCom (DXCM) | United States | $13.337B | 197.65 |
| Hologic (HOLX) | United States | $13.290B | 20.98 |
| STERIS (STE) | Ireland | $12.205B | 28.15 |
| Varian Medical Systems (VAR) | United States | $10.690B | 25.58 |
| ABIOMED (ABMD) | United States | $8.459B | 48.42 |
| Masimo (MASI) | United States | $8.054B | 48.87 |
| SARTORIUS AG (SARTF) | Germany | $6.158B | 54.71 |
| Integra LifeSciences Holdings (IART) | United States | $5.252B | 23.43 |
| Penumbra (PEN) | United States | $5.184B | 186.25 |
| Elekta AB (EKTAY) | Sweden | $5.142B | 39.59 |
| Globus Medical (GMED) | United States | $5.066B | 32.15 |
| LivaNova (LIVN) | United Kingdom | $4.122B | 31.43 |
| Cantel Medical (CMD) | United States | $3.630B | 36.82 |
| Tandem Diabetes Care (TNDM) | United States | $3.605B | 0.00 |
| Nevro (NVRO) | United States | $2.779B | 0.00 |
| Glaukos (GKOS) | United States | $2.693B | 0.00 |
| Wright Medical Group (WMGI) | Netherlands | $2.648B | 232.22 |
| Integer Holdings (ITGR) | United States | $2.527B | 17.87 |
| Nihon Kohden (NHNKY) | Japan | $2.457B | 24.72 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.825B | 33.86 |
| OPKO Health (OPK) | United States | $1.336B | 0.00 |
| Veracyte (VCYT) | United States | $1.247B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $1.116B | 0.00 |
| Silk Road Medical (SILK) | United States | $1.114B | 0.00 |
| CryoLife (CRY) | United States | $1.109B | 105.61 |
| Inogen (INGN) | United States | $1.062B | 26.03 |
| Natus Medical (NTUS) | United States | $1.056B | 24.60 |
| Luminex (LMNX) | United States | $1.018B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.992B | 122.61 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.972B | 30.53 |
| Mesa Laboratories (MLAB) | United States | $0.929B | 42.90 |
| Pacific Biosciences Of California (PACB) | United States | $0.850B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.692B | 22.55 |
| Quotient (QTNT) | Switzerland | $0.581B | 0.00 |
| Intersect ENT (XENT) | United States | $0.577B | 0.00 |
| AxoGen (AXGN) | United States | $0.563B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.560B | 0.00 |
| Si-Bone (SIBN) | United States | $0.464B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.376B | 14.44 |
| ViewRay (VRAY) | United States | $0.375B | 0.00 |
| Fluidigm (FLDM) | United States | $0.373B | 0.00 |
| Sientra (SIEN) | United States | $0.350B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.345B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.336B | 0.00 |
| Accuray (ARAY) | United States | $0.269B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.266B | 45.00 |
| IRadimed (IRMD) | United States | $0.262B | 43.47 |
| SeaSpine Holdings (SPNE) | United States | $0.241B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.241B | 36.22 |
| Neuronetics (STIM) | United States | $0.209B | 0.00 |
| ConforMIS (CFMS) | United States | $0.136B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.128B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.118B | 58.29 |
| Second Sight Medical Products (EYES) | United States | $0.110B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.105B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.071B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.066B | 0.00 |
| Vermillion (VRML) | United States | $0.062B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.050B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.043B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.038B | 0.00 |
| Neovasc (NVCN) | Canada | $0.030B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.026B | 0.00 |
| Nuvectra (NVTR) | United States | $0.025B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.023B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.023B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.022B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.018B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.013B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.012B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.011B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.011B | 0.00 |
| Dynatronics (DYNT) | United States | $0.011B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.010B | 0.00 |
| Avinger (AVGR) | United States | $0.007B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.007B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.004B | 0.00 |
